APO Research
Talk to an analyst

APO RESEARCH · REPORT

Fish-Oil Based Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Fish-Oil Based Drugs Market Outlook and Growth Opportunities 2026

31 December 2025199 pages

Choose your research edition.

Industry ResearchFish-Oil Based Drugs Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Fish-Oil Based Drugs Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Fish-Oil Based Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Fish-Oil Based Drugs Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Fish-Oil Based Drugs Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Fish-Oil Based Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Fish-Oil Based Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Fish-Oil Based Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Fish-Oil Based Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Fish-Oil Based Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Fish-Oil Based Drugs market include Aker Biomarine, BASF SE, Cellana, Clover Corporation, Croda International PLC, GC Rieber Oil, Omega Protein Corporation, Pharma Marine and Solutex GC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Fish-Oil Based Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Fish-Oil Based Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Fish-Oil Based Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Fish-Oil Based Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Fish-Oil Based Drugs Segment by Company

Aker Biomarine

BASF SE

Cellana

Clover Corporation

Croda International PLC

GC Rieber Oil

Omega Protein Corporation

Pharma Marine

Solutex GC

Stepan Company

United Laboratories

Fish-Oil Based Drugs Segment by Type

Salmon

Mackerel

Tuna

Herring

Others

Fish-Oil Based Drugs Segment by Application

Stroke

Dysmenorrhea

Rheumatoid Arthritis

Raynaud's Syndrome

Coronary Heart Disease (CHD)

Other

Fish-Oil Based Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Fish-Oil Based Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Fish-Oil Based Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Fish-Oil Based Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Fish-Oil Based Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fish-Oil Based Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Fish-Oil Based Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fish-Oil Based Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Fish-Oil Based Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Fish-Oil Based Drugs industry.

Chapter 3: Detailed analysis of Fish-Oil Based Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Fish-Oil Based Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Fish-Oil Based Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Fish-Oil Based Drugs Industry Trends Table 2. Fish-Oil Based Drugs Industry Drivers Table 3. Fish-Oil Based Drugs Industry Opportunities and Challenges Table 4. Fish-Oil Based Drugs Industry Restraints Table 5. Global Fish-Oil Based Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Fish-Oil Based Drugs Revenue Share by Company (2021-2026) Table 7. Global Fish-Oil Based Drugs Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Fish-Oil Based Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Fish-Oil Based Drugs Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Fish-Oil Based Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Fish-Oil Based Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Fish-Oil Based Drugs Company, Product Type & Application Table 13. Global Fish-Oil Based Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Fish-Oil Based Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Salmon Table 18. Significant Companies of Mackerel Table 19. Significant Companies of Tuna Table 20. Significant Companies of Herring Table 21. Significant Companies of Others Table 22. Global Fish-Oil Based Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global Fish-Oil Based Drugs Sales Volume by Type (2021-2026) & (K Units) Table 24. Global Fish-Oil Based Drugs Sales Volume by Type (2027-2032) & (K Units) Table 25. Global Fish-Oil Based Drugs Sales Volume Share by Type (2021-2026) Table 26. Global Fish-Oil Based Drugs Sales Volume Share by Type (2027-2032) Table 27. Global Fish-Oil Based Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Fish-Oil Based Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Fish-Oil Based Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Fish-Oil Based Drugs Sales Value Share by Type (2021-2026) Table 31. Global Fish-Oil Based Drugs Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Stroke Table 33. Significant Companies of Dysmenorrhea Table 34. Significant Companies of Rheumatoid Arthritis Table 35. Significant Companies of Raynaud's Syndrome Table 36. Significant Companies of Coronary Heart Disease (CHD) Table 37. Significant Companies of Other Table 38. Global Fish-Oil Based Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Fish-Oil Based Drugs Sales Volume by Application (2021-2026) & (K Units) Table 40. Global Fish-Oil Based Drugs Sales Volume by Application (2027-2032) & (K Units) Table 41. Global Fish-Oil Based Drugs Sales Volume Share by Application (2021-2026) Table 42. Global Fish-Oil Based Drugs Sales Volume Share by Application (2027-2032) Table 43. Global Fish-Oil Based Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 44. Global Fish-Oil Based Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 45. Global Fish-Oil Based Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 46. Global Fish-Oil Based Drugs Sales Value Share by Application (2021-2026) Table 47. Global Fish-Oil Based Drugs Sales Value Share by Application (2027-2032) Table 48. Global Fish-Oil Based Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 49. Global Fish-Oil Based Drugs Sales by Region (2021-2026) & (K Units) Table 50. Global Fish-Oil Based Drugs Sales Market Share by Region (2021-2026) Table 51. Global Fish-Oil Based Drugs Sales by Region (2027-2032) & (K Units) Table 52. Global Fish-Oil Based Drugs Sales Market Share by Region (2027-2032) Table 53. Global Fish-Oil Based Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 54. Global Fish-Oil Based Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 55. Global Fish-Oil Based Drugs Sales Value Share by Region (2021-2026) Table 56. Global Fish-Oil Based Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 57. Global Fish-Oil Based Drugs Sales Value Share by Region (2027-2032) Table 58. Global Fish-Oil Based Drugs Market Average Price (US$/Unit) by Region (2021-2026) Table 59. Global Fish-Oil Based Drugs Market Average Price (US$/Unit) by Region (2027-2032) Table 60. Global Fish-Oil Based Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 61. Global Fish-Oil Based Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Fish-Oil Based Drugs Sales by Country (2021-2026) & (K Units) Table 63. Global Fish-Oil Based Drugs Sales Market Share by Country (2021-2026) Table 64. Global Fish-Oil Based Drugs Sales by Country (2027-2032) & (K Units) Table 65. Global Fish-Oil Based Drugs Sales Market Share by Country (2027-2032) Table 66. Global Fish-Oil Based Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 67. Global Fish-Oil Based Drugs Sales Value Market Share by Country (2021-2026) Table 68. Global Fish-Oil Based Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 69. Global Fish-Oil Based Drugs Sales Value Market Share by Country (2027-2032) Table 70. Aker Biomarine Company Information Table 71. Aker Biomarine Business Overview Table 72. Aker Biomarine Fish-Oil Based Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Aker Biomarine Fish-Oil Based Drugs Product Portfolio Table 74. Aker Biomarine Recent Development Table 75. BASF SE Company Information Table 76. BASF SE Business Overview Table 77. BASF SE Fish-Oil Based Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. BASF SE Fish-Oil Based Drugs Product Portfolio Table 79. BASF SE Recent Development Table 80. Cellana Company Information Table 81. Cellana Business Overview Table 82. Cellana Fish-Oil Based Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Cellana Fish-Oil Based Drugs Product Portfolio Table 84. Cellana Recent Development Table 85. Clover Corporation Company Information Table 86. Clover Corporation Business Overview Table 87. Clover Corporation Fish-Oil Based Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Clover Corporation Fish-Oil Based Drugs Product Portfolio Table 89. Clover Corporation Recent Development Table 90. Croda International PLC Company Information Table 91. Croda International PLC Business Overview Table 92. Croda International PLC Fish-Oil Based Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Croda International PLC Fish-Oil Based Drugs Product Portfolio Table 94. Croda International PLC Recent Development Table 95. GC Rieber Oil Company Information Table 96. GC Rieber Oil Business Overview Table 97. GC Rieber Oil Fish-Oil Based Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. GC Rieber Oil Fish-Oil Based Drugs Product Portfolio Table 99. GC Rieber Oil Recent Development Table 100. Omega Protein Corporation Company Information Table 101. Omega Protein Corporation Business Overview Table 102. Omega Protein Corporation Fish-Oil Based Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Omega Protein Corporation Fish-Oil Based Drugs Product Portfolio Table 104. Omega Protein Corporation Recent Development Table 105. Pharma Marine Company Information Table 106. Pharma Marine Business Overview Table 107. Pharma Marine Fish-Oil Based Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Pharma Marine Fish-Oil Based Drugs Product Portfolio Table 109. Pharma Marine Recent Development Table 110. Solutex GC Company Information Table 111. Solutex GC Business Overview Table 112. Solutex GC Fish-Oil Based Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Solutex GC Fish-Oil Based Drugs Product Portfolio Table 114. Solutex GC Recent Development Table 115. Stepan Company Company Information Table 116. Stepan Company Business Overview Table 117. Stepan Company Fish-Oil Based Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Stepan Company Fish-Oil Based Drugs Product Portfolio Table 119. Stepan Company Recent Development Table 120. United Laboratories Company Information Table 121. United Laboratories Business Overview Table 122. United Laboratories Fish-Oil Based Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. United Laboratories Fish-Oil Based Drugs Product Portfolio Table 124. United Laboratories Recent Development Table 125. Key Raw Materials Table 126. Raw Materials Key Suppliers Table 127. Fish-Oil Based Drugs Distributors List Table 128. Fish-Oil Based Drugs Customers List Table 129. Research Programs/Design for This Report Table 130. Authors List of This Report Table 131. Secondary Sources Table 132. Primary Sources List of Figures Figure 1. Fish-Oil Based Drugs Product Image Figure 2. Global Fish-Oil Based Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Fish-Oil Based Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Fish-Oil Based Drugs Sales (2021-2032) & (K Units) Figure 5. Global Fish-Oil Based Drugs Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Fish-Oil Based Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Salmon Image Figure 10. Mackerel Image Figure 11. Tuna Image Figure 12. Herring Image Figure 13. Others Image Figure 14. Global Fish-Oil Based Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Fish-Oil Based Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Fish-Oil Based Drugs Sales Volume Share by Type (2021-2032) Figure 17. Global Fish-Oil Based Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Fish-Oil Based Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Fish-Oil Based Drugs Sales Value Share by Type (2021-2032) Figure 20. Stroke Image Figure 21. Dysmenorrhea Image Figure 22. Rheumatoid Arthritis Image Figure 23. Raynaud's Syndrome Image Figure 24. Coronary Heart Disease (CHD) Image Figure 25. Other Image Figure 26. Global Fish-Oil Based Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 27. Global Fish-Oil Based Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 28. Global Fish-Oil Based Drugs Sales Volume Share by Application (2021-2032) Figure 29. Global Fish-Oil Based Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Fish-Oil Based Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 31. Global Fish-Oil Based Drugs Sales Value Share by Application (2021-2032) Figure 32. Global Fish-Oil Based Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 33. Global Fish-Oil Based Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 34. Global Fish-Oil Based Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 35. Global Fish-Oil Based Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 36. North America Fish-Oil Based Drugs Sales Value (2021-2032) & (US$ Million) Figure 37. North America Fish-Oil Based Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Europe Fish-Oil Based Drugs Sales Value (2021-2032) & (US$ Million) Figure 39. Europe Fish-Oil Based Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Asia-Pacific Fish-Oil Based Drugs Sales Value (2021-2032) & (US$ Million) Figure 41. Asia-Pacific Fish-Oil Based Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 42. South America Fish-Oil Based Drugs Sales Value (2021-2032) & (US$ Million) Figure 43. South America Fish-Oil Based Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 44. Middle East & Africa Fish-Oil Based Drugs Sales Value (2021-2032) & (US$ Million) Figure 45. Middle East & Africa Fish-Oil Based Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 46. USA Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. USA Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. USA Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Canada Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Canada Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Canada Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Mexico Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Mexico Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Mexico Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Germany Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Germany Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Germany Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. France Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. France Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. France Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. U.K. Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. U.K. Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. U.K. Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Italy Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Italy Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Italy Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Spain Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Spain Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Spain Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Russia Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Russia Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Russia Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Netherlands Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Netherlands Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Netherlands Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Nordic Countries Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Nordic Countries Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Nordic Countries Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. China Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. China Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. China Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Japan Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Japan Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Japan Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. South Korea Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. South Korea Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. South Korea Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. India Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. India Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. India Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Australia Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Australia Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Australia Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Southeast Asia Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Southeast Asia Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Southeast Asia Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Brazil Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Brazil Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Brazil Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Argentina Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Argentina Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Argentina Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Chile Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Chile Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Chile Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Colombia Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Colombia Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Colombia Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Peru Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Peru Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Peru Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Saudi Arabia Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Saudi Arabia Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Israel Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Israel Arabia Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Israel Arabia Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. UAE Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. UAE Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. UAE Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Turkey Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Turkey Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Turkey Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Iran Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Iran Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Iran Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Egypt Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 128. Egypt Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 129. Egypt Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 130. Fish-Oil Based Drugs Value Chain Figure 131. Manufacturing Cost Structure Figure 132. Fish-Oil Based Drugs Sales Mode & Process Figure 133. Direct Comparison with Distribution Share Figure 134. Distributors Profiles Figure 135. Years Considered Figure 136. Research Process Figure 137. Key Executives Interviewed

Scope & coverage.

Types
  • Salmon
  • Mackerel
  • Tuna
  • Herring
  • Others
Applications
  • Stroke
  • Dysmenorrhea
  • Rheumatoid Arthritis
  • Raynaud's Syndrome
  • Coronary Heart Disease (CHD)
  • Other
Companies covered
  • Aker Biomarine
  • BASF SE
  • Cellana
  • Clover Corporation
  • Croda International PLC
  • GC Rieber Oil
  • Omega Protein Corporation
  • Pharma Marine
  • Solutex GC
  • Stepan Company
  • United Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Fish-Oil Based Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Fish-Oil Based Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Fish-Oil Based Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Fish-Oil Based Drugs Market Dynamics
  1. 2.1 Fish-Oil Based Drugs Industry Trends
  2. 2.2 Fish-Oil Based Drugs Industry Drivers
  3. 2.3 Fish-Oil Based Drugs Industry Opportunities and Challenges
  4. 2.4 Fish-Oil Based Drugs Industry Restraints
3 Fish-Oil Based Drugs Market by Company
  1. 3.1 Global Fish-Oil Based Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Fish-Oil Based Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Fish-Oil Based Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Fish-Oil Based Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Fish-Oil Based Drugs Company Ranking (2024-2026)
  6. 3.6 Global Fish-Oil Based Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Fish-Oil Based Drugs Company Product Type and Application
  8. 3.8 Global Fish-Oil Based Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Fish-Oil Based Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Fish-Oil Based Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Fish-Oil Based Drugs Market by Type
  1. 4.1 Fish-Oil Based Drugs Type Introduction
  2. 4.1.1 Salmon
  3. 4.1.2 Mackerel
  4. 4.1.3 Tuna
  5. 4.1.4 Herring
  6. 4.1.5 Others
  7. 4.2 Global Fish-Oil Based Drugs Sales Volume by Type
  8. 4.2.1 Global Fish-Oil Based Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Fish-Oil Based Drugs Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Fish-Oil Based Drugs Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Fish-Oil Based Drugs Sales Value by Type
  12. 4.3.1 Global Fish-Oil Based Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Fish-Oil Based Drugs Sales Value by Type (2021-2032)
  14. 4.3.3 Global Fish-Oil Based Drugs Sales Value Share by Type (2021-2032)
5 Fish-Oil Based Drugs Market by Application
  1. 5.1 Fish-Oil Based Drugs Application Introduction
  2. 5.1.1 Stroke
  3. 5.1.2 Dysmenorrhea
  4. 5.1.3 Rheumatoid Arthritis
  5. 5.1.4 Raynaud's Syndrome
  6. 5.1.5 Coronary Heart Disease (CHD)
  7. 5.1.6 Other
  8. 5.2 Global Fish-Oil Based Drugs Sales Volume by Application
  9. 5.2.1 Global Fish-Oil Based Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Fish-Oil Based Drugs Sales Volume by Application (2021-2032)
  11. 5.2.3 Global Fish-Oil Based Drugs Sales Volume Share by Application (2021-2032)
  12. 5.3 Global Fish-Oil Based Drugs Sales Value by Application
  13. 5.3.1 Global Fish-Oil Based Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global Fish-Oil Based Drugs Sales Value by Application (2021-2032)
  15. 5.3.3 Global Fish-Oil Based Drugs Sales Value Share by Application (2021-2032)
6 Fish-Oil Based Drugs Regional Sales and Value Analysis
  1. 6.1 Global Fish-Oil Based Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Fish-Oil Based Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Fish-Oil Based Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Fish-Oil Based Drugs Sales by Region (2027-2032)
  5. 6.3 Global Fish-Oil Based Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Fish-Oil Based Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Fish-Oil Based Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Fish-Oil Based Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Fish-Oil Based Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Fish-Oil Based Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Fish-Oil Based Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Fish-Oil Based Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Fish-Oil Based Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Fish-Oil Based Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Fish-Oil Based Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Fish-Oil Based Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Fish-Oil Based Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Fish-Oil Based Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Fish-Oil Based Drugs Sales Value Share by Country, 2025 VS 2032
7 Fish-Oil Based Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Fish-Oil Based Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Fish-Oil Based Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Fish-Oil Based Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Fish-Oil Based Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Fish-Oil Based Drugs Sales by Country (2027-2032)
  6. 7.4 Global Fish-Oil Based Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Fish-Oil Based Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Fish-Oil Based Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Fish-Oil Based Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Fish-Oil Based Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Fish-Oil Based Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Aker Biomarine
  2. 8.1.1 Aker Biomarine Company Information
  3. 8.1.2 Aker Biomarine Business Overview
  4. 8.1.3 Aker Biomarine Fish-Oil Based Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Aker Biomarine Fish-Oil Based Drugs Product Portfolio
  6. 8.1.5 Aker Biomarine Recent Developments
  7. 8.2 BASF SE
  8. 8.2.1 BASF SE Company Information
  9. 8.2.2 BASF SE Business Overview
  10. 8.2.3 BASF SE Fish-Oil Based Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 BASF SE Fish-Oil Based Drugs Product Portfolio
  12. 8.2.5 BASF SE Recent Developments
  13. 8.3 Cellana
  14. 8.3.1 Cellana Company Information
  15. 8.3.2 Cellana Business Overview
  16. 8.3.3 Cellana Fish-Oil Based Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Cellana Fish-Oil Based Drugs Product Portfolio
  18. 8.3.5 Cellana Recent Developments
  19. 8.4 Clover Corporation
  20. 8.4.1 Clover Corporation Company Information
  21. 8.4.2 Clover Corporation Business Overview
  22. 8.4.3 Clover Corporation Fish-Oil Based Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Clover Corporation Fish-Oil Based Drugs Product Portfolio
  24. 8.4.5 Clover Corporation Recent Developments
  25. 8.5 Croda International PLC
  26. 8.5.1 Croda International PLC Company Information
  27. 8.5.2 Croda International PLC Business Overview
  28. 8.5.3 Croda International PLC Fish-Oil Based Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Croda International PLC Fish-Oil Based Drugs Product Portfolio
  30. 8.5.5 Croda International PLC Recent Developments
  31. 8.6 GC Rieber Oil
  32. 8.6.1 GC Rieber Oil Company Information
  33. 8.6.2 GC Rieber Oil Business Overview
  34. 8.6.3 GC Rieber Oil Fish-Oil Based Drugs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 GC Rieber Oil Fish-Oil Based Drugs Product Portfolio
  36. 8.6.5 GC Rieber Oil Recent Developments
  37. 8.7 Omega Protein Corporation
  38. 8.7.1 Omega Protein Corporation Company Information
  39. 8.7.2 Omega Protein Corporation Business Overview
  40. 8.7.3 Omega Protein Corporation Fish-Oil Based Drugs Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Omega Protein Corporation Fish-Oil Based Drugs Product Portfolio
  42. 8.7.5 Omega Protein Corporation Recent Developments
  43. 8.8 Pharma Marine
  44. 8.8.1 Pharma Marine Company Information
  45. 8.8.2 Pharma Marine Business Overview
  46. 8.8.3 Pharma Marine Fish-Oil Based Drugs Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Pharma Marine Fish-Oil Based Drugs Product Portfolio
  48. 8.8.5 Pharma Marine Recent Developments
  49. 8.9 Solutex GC
  50. 8.9.1 Solutex GC Company Information
  51. 8.9.2 Solutex GC Business Overview
  52. 8.9.3 Solutex GC Fish-Oil Based Drugs Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Solutex GC Fish-Oil Based Drugs Product Portfolio
  54. 8.9.5 Solutex GC Recent Developments
  55. 8.10 Stepan Company
  56. 8.10.1 Stepan Company Company Information
  57. 8.10.2 Stepan Company Business Overview
  58. 8.10.3 Stepan Company Fish-Oil Based Drugs Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Stepan Company Fish-Oil Based Drugs Product Portfolio
  60. 8.10.5 Stepan Company Recent Developments
  61. 8.11 United Laboratories
  62. 8.11.1 United Laboratories Company Information
  63. 8.11.2 United Laboratories Business Overview
  64. 8.11.3 United Laboratories Fish-Oil Based Drugs Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 United Laboratories Fish-Oil Based Drugs Product Portfolio
  66. 8.11.5 United Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Fish-Oil Based Drugs Value Chain Analysis
  2. 9.1.1 Fish-Oil Based Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Fish-Oil Based Drugs Sales Mode & Process
  6. 9.2 Fish-Oil Based Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Fish-Oil Based Drugs Distributors
  9. 9.2.3 Fish-Oil Based Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst